Insights

We share our knowledge and expertise to update our community and clients about legal developments in Turkey.

Filters

Protection of Personal Data In Turkiye – General Approach

The primary regulation on the protection of personal data in Turkiye is the Personal Data Protection Law No. 6698 (“Law”), which came into force in 2016. Based on the European Council Data Protection Directive 95/46/EC, the Law has been influenced by the provisions of the European Union General Data Protection Regulation (“GDPR”) and its implementation is shaped by both the GDPR and the decisions of European data protection authorities. The Law adopts similar objectives and… »

Artificial Intelligence and Copyright: Challenges and Opportunities

AI technologies and their relationship with Intellectual Property (IP) rights have remained a prominent topic on the global agenda this year, as they were last year. With the increasing presence of generative AI models such as ChatGPT, BERT, LaMDA, and DALL-E2, which are capable of creating original content by processing data like text, images and sound, debates continue over whether the outputs generated by these models qualify as copyrighted works, who owns the rights to… »

Competition Investigations in the Shadow of the Settlement Procedure

Updates -

According to the Competition Authority's (“Authority”) activity report for 2023, it is seen that 68 of the 117 investigation files were concluded with settlements and 28 files were concluded with commitments. Although the activity report for 2024 has not yet been published by the Authority, announcements of final decisions on its website indicate that the majority of investigations in 2024 have also been concluded through settlement. Investigation of competition law… »

Medicines and Medical Devices Sectors: Current Status and Evolving Dynamics

Updates -

The pharmaceutical sector saw a 2.7% increase in production in 2023. However, between January and July of 2024, there was a 5.2% decrease compared to the same period in the previous year. By 2023, pharmaceutical imports increased by 8.8% reaching a value of 5.4 billion USD, while pharmaceutical exports grew by 15.8% to the size of 2.2 billion USD. In the first half of 2024, exports rose by 1.9%, while imports increased by 4.9% [1]. In 2023, the Turkish pharmaceutical market… »

Named Patient Program

Updates -

The Named Patient Programs (NPP) are import regimes that allow medicines not authorized in Türkiye or authorized but unavailable for various reasons to be imported from abroad upon request by a physician. Following publication of the Regulation on the Importation of Medicines from Abroad ("NPP Regulation") published on 3 February 2023, the roles of stakeholders in the relevant process have been clarified. According to this NPP Regulation, institutions and organisations… »

Developments in the Field of Medical Devices

Updates -

On 26 May 2023, significant changes were made to the Medical Device Promotion Regulation. These changes introduced several new procedures to the medical device sector. Rather than being regulated under separate legislation, these procedures were incorporated into the existing Medical Device Promotion Regulation. According to the updated regulation, additional obligations have been introduced for authorised sales centres for medical devices. These include providing technical… »

Use of Hemp in Production of Pharmaceuticals

Updates -

Hemp cultivation in Türkiye came to the forefront with the “Symposium on Local Governments in the Presidential Government System” held on 9 January 2019, followed by the preparation of the “Report and Action Plan on Industrial Hemp Cultivation in Türkiye”. The hemp cultivation reached a significant stage with the publication of the Law on Amendments to the Forestry Law and Certain Laws on 5 April 2025. This law encourages the production of fibre, seeds, and stems, with the… »

Interactions with Health Care Professionals, Transfer of Values and Conditions of Payment

Updates -

Promotion activities for pharmaceutical products for human use are regulated under the Regulation on the Promotion of Medicinal Products for Human Use dated 3 July 2015 (“Promotion Regulation”). The Promotion Regulation stipulates that the promotion of pharmaceutical products can only be conducted with healthcare professionals such as doctors, dentists, and pharmacists. As a result, the interaction of pharmaceutical companies with patients are limited, and direct… »

Arbitration Procedures and Practice 2024 in Türkiye: Overview

Legislative Framework Applicable Legislation 1. What legislation applies to arbitration? The main arbitration legislation in Türkiye is: The International Arbitration Code (No. 4686), which applies to an international arbitration seated in Türkiye and to an arbitration where its application is agreed by the parties. The Civil Procedure Code (No. 6100), which applies to a domestic arbitration. The arbitration laws in the International Arbitration Code and the Civil… »

Significant Developments in the Implementation of the Turkish Commercial Code in 2025

Existing Facilitations for Capital Loss and Over-Indebtedness Calculations are Extended until 2026 Article 376 of the Turkish Commercial Code numbered 6102 (the “TCC”) regulates the measures to be taken and the precautions to be implemented by the board of directors of the company, and the procedures to be followed in cases where the company suffers capital loss or becomes over-indebted, to ensure the protection of the financial structure of the company and to secure the… »

New Regulation on Electronic Maintenance of Commercial Books Not Related to the Accounting of the Business

Updates -

With the Communiqué on Maintenance of Commercial Books Not Related to the Accounting of the Business in Electronic Form (the “Communiqué”) published in the Official Gazette dated 14 February 2025, it has become mandatory for companies to keep their commercial books not related to the accounting of the business electronically as of July 1, 2025. Books and Enterprises within the Scope of the Communiqué The commercial books, which have been made mandatory to be kept… »

The Regional Administrative Court’s Decision on Trade Secrets And The Administration’s Responsibility Against Unfair Competition

Protecting patent rights in a timely manner is crucial for original pharmaceutical product manufacturers, particularly in being informed of potential infringements before an infringing product enters the market. However, information requests submitted by legal representatives of original drug marketing authorisation (MA) holders regarding the authorisation files of generic companies—who seek approval through an abridged application referencing the original pharmaceuticals—are… »